TRPV1 Activation Attenuates High-Salt Diet-Induced Cardiac Hypertrophy and Fibrosis through PPAR- δ Upregulation

PPAR Research

Volumn 2014, Issue , 2014, Pages

  Gao, Feng ^a   Liang, Yi ^a   Wang, Xiang ^a   Lu, Zongshi ^a   Li, Li ^a   Zhu, Shanjun ^b   Liu, Daoyan ^a   Yan, Zhencheng ^a   Zhu, Zhiming ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; CAPSAICIN; COLLAGEN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INDUCIBLE NITRIC OXIDE SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; REACTIVE OXYGEN METABOLITE; UNCOUPLING PROTEIN 2; VANILLOID RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; MALE; MOUSE; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SALT INTAKE; SIGNAL TRANSDUCTION;

EID: 84935001820     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2014/491963     Document Type: Article

References (42)

1. + signaling pathway", Journal of Cellular Biochemistry, vol. 106, no. 5, pp. 823-834, 2009.
2. F. J. He and G. A. MacGregor, "A comprehensive review on salt and health and current experience of worldwide salt reduction programmes", Journal of Human Hypertension, vol. 23, no. 6, pp. 363-384, 2009.
3. D. N. Ferreira, I. A. Katayama, I. B. Oliveira et al., "Salt-induced cardiac hypertrophy and interstitial fibrosis are due to a blood pressure-independent mechanism in Wistar rats", Journal of Nutrition, vol. 140, no. 10, pp. 1742-1751, 2010.
4. H. Takeshima, N. Kobayashi, W. Koguchi, M. Ishikawa, F. Sugiyama, and T. Ishimitsu, "Cardioprotective effect of a combination of Rho-kinase inhibitor and P38 MAPK inhibitor on cardiovascular remodeling and oxidative stress in Dahl rats", Journal of Atherosclerosis and Thrombosis, vol. 19, no. 4, pp. 326-336, 2012.
5. H. Tsutsui, T. Ide, S. Hayashidani et al., "Effects of ACE inhibition on left ventricular failure and oxidative stress in dahl salt-sensitive rats", Journal of Cardiovascular Pharmacology, vol. 37, no. 6, pp. 725-733, 2001.
6. P. J. H. Smeets, B. E. J. Teunissen, A. Planavila et al., "Inflammatory pathways are activated during cardiomyocyte hypertrophy and attenuated by peroxisome proliferator-activated receptors PPARα and PPARδ", Journal of Biological Chemistry, vol. 283, no. 43, pp. 29109-29118, 2008.
7. M. Pesant, S. Sueur, P. Dutartre et al., "Peroxisome proliferatoractivated receptor δ (PPARδ) activation protects H9c2 cardiomyoblasts from oxidative stress-induced apoptosis", Cardiovascular Research, vol. 69, no. 2, pp. 440-449, 2006.
8. M. J. Caterina, M. A. Schumacher, M. Tominaga, T. A. Rosen, J. D. Levine, and D. Julius, "The capsaicin receptor: a heatactivated ion channel in the pain pathway", Nature, vol. 389, no. 6653, pp. 816-824, 1997.
9. D. Yang, Z. Luo, S. Ma et al., "Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension", Cell Metabolism, vol. 12, no. 2, pp. 130-141, 2010.
10. X. Hao, J. Chen, Z. Luo et al., "TRPV1 activation prevents highsalt diet-induced nocturnal hypertension in mice", Pflugers Archiv European Journal of Physiology, vol. 461, no. 3, pp. 345-353, 2011.
11. L. Li, F. Wang, X. Wei et al., "Transient receptor potential vanilloid 1 activation by dietary capsaicin promotes urinary Sodium excretion by inhibiting epithelial Sodium channel α subunit-mediated Sodium reabsorption", Hypertension. In Press.
12. W. Huang, J. Rubinstein, A. R. Prieto, L. V. Thang, and D. H. Wang, "Transient receptor potential vanilloid gene deletion exacerbates inflammation and atypical cardiac remodeling after myocardial infarction", Hypertension, vol. 53, no. 2, pp. 243-250, 2009.
13. D. Westermann, A. Riad, U. Richter et al., "Enhancement of the endothelial NO synthase attenuates experimental diastolic heart failure", Basic Research in Cardiology, vol. 104, no. 5, pp. 499-509, 2009.
14. S. Li, S. Zhong, K. Zeng et al., "Blockade of NF-κB by pyrrolidine dithiocarbamate attenuates myocardial inflammatory response and ventricular dysfunction following coronary microembolization induced by homologous microthrombi in rats", Basic Research in Cardiology, vol. 105, no. 1, pp. 139-150, 2010.
15. G. La Rocca, A. Di Stefano, E. Eleuteri et al., "Oxidative stress inducesmyeloperoxidase expression in endocardial endothelial cells from patients with chronic heart failure", Basic Research in Cardiology, vol. 104, no. 3, pp. 307-320, 2009.
16. J. P. Despres, B. J. Arsenault, M. Côté, A. Cartier, and I. Lemieux, "Abdominal obesity: the cholesterol of the 21st century?" Canadian Journal of Cardiology, vol. 24, supplement D, pp. 7D-12D, 2008.
17. G. Hu, Q. Qiao, and J. Tuomilehto, "Nonhypertensive cardiac effects of a high salt diet", Current Hypertension Reports, vol. 4, no. 1, pp. 13-17, 2002.
18. M. J. Caterina, A. Leffler, A. B. Malmberg et al., "Impaired nociception and pain sensation in mice lacking the capsaicin receptor", Science, vol. 288, no. 5464, pp. 306-313, 2000.
19. L. L. Zhang, D. Y. Liu, L. Q. Ma et al., "Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity", Circulation Research, vol. 100, no. 7, pp. 1063-1070, 2007.
20. Z. Luo, L. Ma, Z. Zhao et al., "TRPV1 activation improves exercise endurance and energy metabolism through PGC-1α upregulation in mice", Cell Research, vol. 22, no. 3, pp. 551-564, 2012.
21. L. Sheng, P. Ye, Y. Liu, C. Han, and Z. Zhang, "Peroxisome proliferator-activated receptor α/δ activation improves angiotensin II-induced cardiac hypertrophy in vitro", Clinical and Experimental Hypertension, vol. 30, no. 2, pp. 109-119, 2008.
22. Y. Takata, J. Liu, F. Yin et al., "PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis", Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 11, pp. 4277-4282, 2008.
23. T. L. Yue, S. S. Nerurkar, W. Bao et al., "In vivo activation of peroxisome proliferator-activated receptor-δ protects the heart from ischemia/reperfusion injury in Zucker fatty rats", Journal of Pharmacology and Experimental Therapeutics, vol. 325, no. 2, pp. 466-474, 2008.
24. T. L. Graham, C. Mookherjee, K. E. Suckling, C. N. A. Palmer, and L. Patel, "The PPARdelta agonistGW0742X reduces atherosclerosis in LDLR (-/-) mice", Atherosclerosis, vol. 181, no. 1, pp. 29-37, 2005.
25. B. E. Teunissen, P. J. Smeets, P. H. Willemsen, L. J. DeWindt, G. J. Van der Vusse, and M. Van Bilsen, "Activation of PPARdelta inhibits cardiac fibroblast proliferation and the transdifferentiation into myofibroblasts", Cardiovascular Research, vol. 75, no. 3, pp. 519-529, 2007.
26. A. J. Gilde, K. A. van der Lee, P. H. Willemsen et al., "Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism", Circulation Research, vol. 92, no. 5, pp. 518-524, 2003.
27. E. Chevillotte, J. Rieusset, M. Roques, M. Desage, and H. Vidal, "The regulation of uncoupling protein-2 gene expression by ω-6 polyunsaturated fatty acids in human skeletal muscle cells involves multiple pathways, including the nuclear receptor peroxisome proliferator-activated receptor β", The Journal of Biological Chemistry, vol. 276, no. 14, pp. 10853-10860, 2001.
28. J. Aubert, O. Champigny, P. Saint-Marc et al., "Up-regulation of UCP-2 gene expression by PPAR agonists in preadipose and adipose cells", Biochemical and Biophysical Research Communications, vol. 238, no. 2, pp. 606-611, 1997.
29. J. Pi, Y. Bai, K. W. Daniel et al., "Persistent oxidative stress due to absence of uncoupling protein 2 associated with impaired pancreatic β-cell function", Endocrinology, vol. 150, no. 7, pp. 3040-3048, 2009.
30. H. Bugger, C. Guzman, C. Zechner, M. Palmeri, K. S. Russell, and R. R. Russell III, "Uncoupling protein downregulation in doxorubicin-induced heart failure improves mitochondrial coupling but increases reactive oxygen species generation", Cancer Chemotherapy and Pharmacology, vol. 67, no. 6, pp. 1381-1388, 2011.
31. Shc and monoamine oxidase", Basic Research in Cardiology, vol. 104, no. 2, pp. 131-139, 2009.
32. S. Ma, L. Ma, D. Yang et al., "Uncoupling protein 2 ablation exacerbates high-salt intake-induced vascular dysfunction", American Journal of Hypertension, vol. 23, no. 8, pp. 822-828, 2010.
33. Y. Teshima, M. Akao, S. P. Jones, and E. Marbán, "Uncoupling protein-2 overexpression inhibitsmitochondrial death pathway in cardiomyocytes", Circulation Research, vol. 93, no. 3, pp. 192-200, 2003.
34. B. Zheng, L. Cao, Q. Zeng, X. Wang, D. Li, and Y. Liao, "Inhibition of NOS2 ameliorates cardiac remodeling, improves heart function after myocardial infarction in rats", Basic Research in Cardiology, vol. 99, no. 4, pp. 264-271, 2004.
35. I. N. Mungrue, R. Gros, X. You et al., "Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death", Journal of Clinical Investigation, vol. 109, no. 6, pp. 735-743, 2002.
36. A. Kapoor, M. Collino, S. Castiglia, R. Fantozzi, and C. Thiemermann, "Activation of peroxisome proliferator-activated receptor-β/δ attenuates myocardial ischemia/reperfusion injury in the rat", Shock, vol. 34, no. 2, pp. 117-124, 2010.
37. A. Kapoor, Y. Shintani, M. Collino et al., "Protective role of peroxisome proliferator-activated receptor-β/δ in septic shock", American Journal of Respiratory and Critical Care Medicine, vol. 182, no. 12, pp. 1506-1515, 2010.
38. P. Zhang, X. Xu, X. Hu, E. D. van Deel, G. Zhu, and Y. Chen, "Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure", Circulation Research, vol. 100, no. 7, pp. 1089-1098, 2007.
39. S. Umar and A. van der Laarse, "Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart", Molecular and Cellular Biochemistry, vol. 333, no. 1-2, pp. 191-201, 2010.
40. Y. H. Liu, O. A. Carretero, O. H. Cingolani et al., "Role of inducible nitric oxide synthase in cardiac function and remodeling in mice with heart failure due tomyocardial infarction", American Journal of Physiology-Heart and Circulatory Physiology, vol. 289, no. 6, pp. H2616-H2623, 2005.
41. W. Nadruz Jr., V. J. Lagosta, H. Moreno Jr., O. R. Coelho, and K. G. Franchini, "Simvastatin prevents load-induced protein tyrosine nitration in overloaded hearts", Hypertension, vol. 43, no. 5, pp. 1060-1066, 2004.
42. M. Galuppo, R. Di Paola, E. Mazzon et al., "Role of PPAR-δ in the development of zymosan-inducedmultiple organ failure: an experiment mice study", Journal of Inflammation, vol. 7, article 12, 2010.